ArticleAmerican journal of cancer research2023

Combination of systemic immune-inflammation index and albumin-bilirubin grade predict prognosis of regorafenib in unresectable hepatocellular carcinoma.

Wei Teng et al.PubMed ↗Full text ↗

No numbers read from the abstract.